Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling.
Purity:
>98.0%
CAS Number:
[2235419-62-0]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted